To join this case, fill out the form below
CinCor Pharma, Inc. Investigation
By clicking on the Submit button below, I acknowledge that I have read the Retainer Agreement and agree to retain WeissLaw LLP to file an action against the Company in connection with this matter. WeissLaw LLP will prosecute the action on a contingent fee basis and will advance all costs and expenses.
By clicking on the Submit button below, I acknowledge that I have read the Derivative Retention Letter and agree to retain WeissLaw LLP to file an action against the Company in connection with this matter. WeissLaw LLP will prosecute the action on a contingent fee basis and will advance all costs and expenses.
A signed Retainer Agreement will be sent to your email shortly.
Oops! Something went wrong while submitting the form.

CinCor Pharma, Inc. Investigation

We are investigating possible breaches of fiduciary duty and other violations of law by the board of directors of CinCor Pharma, Inc. (“CinCor” or the “Company”) (NASDAQ: CINC), in connection with the proposed acquisition of the Company by Astra Zeneca PLC (NASDAQ: AZN) via tender offer.  Under the terms of the merger agreement, the Company’s shareholders will receive $26.00 in cash for each share of CinCor common stock owned, plus a non-tradable contingent value right (“CVR”) of $10.00.

Weiss Law is investigating whether (i) CinCor’s board of directors acted in the best interests of Company shareholders in agreeing to the proposed transaction, (ii) the $26.00 per share merger consideration adequately compensates CinCor’s shareholders, and (iii) all information regarding the sales process and valuation of the transaction will be fully and fairly disclosed.  Notably, the merger consideration is below the $30 median price target set by analysts, and at least one analyst set a price target for the Company of $50 per share, $24.00 above the per-share merger consideration.

Other Cases

March 11, 2024

Superior Drilling Products, Inc. Investigation

We are investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Superior Drilling Products, Inc. (“Superior Drilling” or the “Company”) (NYSE: SDPI), in connection with its acquisition by Drilling Tools International Corp. (“DTI”) (NASDAQ: DTI) . Under the merger agreement, DTI agreed to acquire Superior Drilling for total consideration of approximately $32.2 million payable in cash and DTI stock.

Join Case →

March 11, 2024

The L.S. Starrett Company Investigation

We are investigating possible breaches of fiduciary duty and other violations of law by the board of directors of The L.S. Starrett Company (“Starrett” or the “Company”) (NYSE: SCX) in connection with its acquisition by an affiliate of MiddleGround Capital. Under the merger agreement, the Company’s shareholders will receive $16.19 per share.

Join Case →

February 22, 2024

VIZIO Holding Corp. Investigation

We are investigating possible breaches of fiduciary duty and other violations of law by the board of VIZIO Holding Corp. (“VIZIO” or the “Company”) (NYSE: VZIO) in connection with its acquisition by Walmart Inc. (NYSE: WMT). Under the merger agreement, the Company’s shareholders will receive $11.50 per share. The transaction is valued at approximately $2.3 billion.

Join Case →

Where to find us?

new york

305 Broadway, 7th FI
New York, NY 10007
(212) 682-3025

california

8383 Wilshire Blvd., Suite 935
Beverly Hills, CA 90211
(310) 208-2800

georgia

476 Hardendorf Ave. NE
Atlanta, GA 30307
(404) 692-7910

NEW JERSEY

4 Brighton Rd, Suite. 204
Clifton, NJ 07012

Copyright 2022 Weiss Law. All rights reserved

Attorney AdvertisingLegal

Design by Cramdyn